Saturday , November 2 2024
Home / SNB & CHF / United States regulator approves Roche’s Covid-19 antibody test

United States regulator approves Roche’s Covid-19 antibody test

Summary:
Through a blood sample, the test can detect antibodies to the new coronavirus, which could signal a person may have already been infected. (Copyright 2020 The Associated Press. All Rights Reserved.) The US Food and Drug Administration (FDA) has given emergency approval for use of the serological test developed by Swiss pharmaceutical giant Roche, the company announced on Sunday. The test is designed to determine whether a person has been exposed to the new coronavirus and developed antibodies against the disease. The Basel-based firm says that its Elecsys Anti-SARS-CoV-2 test has a specificity rate of 99.8% – which lowers the chance of false positives – and detects antibodies with 100% sensitivity. Roche has started shipping the new test to laboratories around the

Topics:
Swissinfo considers the following as important: , , , , ,

This could be interesting, too:

Guillermo Alcala writes USD/CHF slides to test 0.8645 support with US inflation data on tap

Swissinfo writes Swiss central bank posts CHF62.5bn profit

Nachrichten Ticker - www.finanzen.ch writes Trump-Faktor und Marktbedingungen könnten für neuen Bitcoin-Rekord sorgen

Charles Hugh Smith writes Is Social Media Actually “Media,” Or Is It Something Else?

United States regulator approves Roche’s Covid-19 antibody test

Through a blood sample, the test can detect antibodies to the new coronavirus, which could signal a person may have already been infected. (Copyright 2020 The Associated Press. All Rights Reserved.)

The US Food and Drug Administration (FDA) has given emergency approval for use of the serological test developed by Swiss pharmaceutical giant Roche, the company announced on Sunday.

The test is designed to determine whether a person has been exposed to the new coronavirus and developed antibodies against the disease.

The Basel-based firm says that its Elecsys Anti-SARS-CoV-2 test has a specificity rate of 99.8% – which lowers the chance of false positives – and detects antibodies with 100% sensitivity.

Roche has started shipping the new test to laboratories around the world and says it plans to increase production to “high dougle-digit millions per month” to supply countries that accept the CE mark as well as the US.

Scientists worldwide are in a race to develop serological tests, as results can help policy-makers better understand the disease, determine who may have had the virus and who may have immunity, and what measures may still be needed to fight the pandemic.


Tags: ,,
About Swissinfo
Swissinfo
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.

Leave a Reply

Your email address will not be published. Required fields are marked *